Harrow HROW
NASDAQ HROW
$40.95 -1.11 (-2.64%)
At close: Aug 21, 2026 · 4:00 PM EDT

Harrow (HROW) Return on Invested Capital Growth (3y) (2025)

Harrow (HROW) Return on Invested Capital Growth (3y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC Growth (3y) (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 0.00
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 0.00
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 0.00
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 5.00
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Harrow 1.53 Bn 1.45 Bn 50.36 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 26.00